药物耐药性的膀机制在复合体寄生虫中的药物耐药性
Kasturi Haldar1, Souvik Bhattacharjee2
1Department of Biological Sciences, Boler-Parseghian Center for Rare and Neglected Diseases, Eck Institute of Global Health, University of Notre Dame, Notre Dame, Indiana, USA.
Microbiology and molecular biology reviews : MMBR
|January 24, 2025
概括
膀机制驱动寄生虫的药物耐药性,如疟原虫,引起疟疾. 了解这些囊泡为抗药性疟疾和其他复合体疾病提供了新的策略.
科学领域:
- 寄生虫学的寄生虫学
- 分子生物学分子生物学
- 药物耐药性机制 药物耐药性机制
背景情况:
- 膀机制对细胞功能至关重要,并与各种生物体的耐药性有关.
- 包括Plasmodium和Toxoplasma在内的猿类复杂寄生虫对人类和动物健康构成重大威胁.
- 阿尔特米西宁是必不可少的抗疟疾药物,但耐药性是全球日益关注的问题.
研究的目的:
- 审查和综合关于复杂寄生虫药物耐药性的囊泡机制的知识.
- 根据机械学和进化学的见解,提出一种新的塑菌对艺术菌素的耐药性模型.
- 将这些发现置于相关的原生动物病原体中更广泛的临床耐药性的背景中.
主要方法:
- 文献综述和综合关于囊泡运输和耐药性的现有研究.
- 对来自Plasmodium,Toxoplasma和其他病原性真核生物的机械和进化数据进行比较分析.
- 整合发现,以开发一种新型的素抗性模型.
主要成果:
- 囊泡在细胞过程中扮演着不同的角色,包括 prokaryotes 和 eukaryotes 中的耐药性.
- 细胞外囊泡被确定为寄生虫原生动物中药物耐药性的关键媒介.
- 提出了一种新的Plasmodium artemisinin耐药性的模型,整合了囊泡机制.
结论:
- 膀运输是杂虫寄生虫耐药性的一个关键,被低估的因素.
- 向囊泡机制可能为抗疟疾和毒素菌提供新的治疗策略.
- 对复合体中耐药性的全面了解对于公共卫生至关重要.
相关概念视频
01:23Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
381
Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
381
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
01:06Carrier-Mediated Transport
243
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
243
01:20Desensitization and Tachyphylaxis
1.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.5K
01:24Cellular Membranes and Drug Transport
267
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
267
01:30ATP Driven Pumps III: V-type Pumps
3.5K
V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
3.5K